// Jun 16, 2026 | Outsourced Pharma Capabilities Update
Scaling Cell Therapy Manufacturing: From Tech Transfer to High-Volume Readiness
Courtney Keiser
Senior Director, CMC Operations & Program Management
Christopher Shumway
Senior Director Manufacturing
Overview
Commercial cell therapy raises the bar on throughput, reproducibility, and cost, even for processes designed with scale in mind. This session lays out a practical roadmap for that step-change: facility design, process standardization, and digital execution chosen together, not bolted on. It covers a tech transfer model built for scale and closes with the Partner-in-Plant model, where embedded teams and integrated training standardize best practices, reduce variability, and accelerate ramp to scale.